CoreValve has pioneered the Transcatheter Aortic Valve Replacement (TAVR) technology, providing a minimally invasive alternative to open-heart surgery for heart disease sufferers
CoreValve has pioneered the Transcatheter Aortic Valve Replacement (TAVR) technology, providing a minimally invasive alternative to open-heart surgery for heart disease sufferers. The company has treated over 25,000 patients worldwide and was acquired by Medtronic in 2009.